Mauro Buzzo
Aviano, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
CYP2D6 and CYP2C8 pharmacogenetics and pharmacological interactions to predict imatinib plasmatic exposure in GIST patients.
Journal: British journal of clinical pharmacology
Published: June 17, 2022
A new dried blood spot LC-MS/MS method for therapeutic drug monitoring of palbociclib, ribociclib, and letrozole in patients with cancer.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences
Published: June 24, 2021
Simultaneous quantification of palbociclib, ribociclib and letrozole in human plasma by a new LC-MS/MS method for clinical application.
Journal: PloS one
Published: September 17, 2019
A new high-performance liquid chromatography-tandem mass spectrometry method for the determination of sunitinib and N-desethyl sunitinib in human plasma: Light-induced isomerism overtaking towards therapeutic drug monitoring in clinical routine.
Journal: Journal of pharmaceutical and biomedical analysis
Published: June 27, 2019
Development and validation of LC-MS/MS method for imatinib and norimatinib monitoring by finger-prick DBS in gastrointestinal stromal tumor patients.
Journal: PloS one
Published: June 18, 2019
Analytical aspects of sunitinib and its geometric isomerism towards therapeutic drug monitoring in clinical routine.
Journal: Journal of pharmaceutical and biomedical analysis
Published: April 04, 2018
Peptide biosensors for anticancer drugs: Design in silico to work in denaturizing environment.
Journal: Biosensors & bioelectronics
Published: June 01, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026